Previous close | 0.1000 |
Open | 0.1000 |
Bid | 0.0000 |
Ask | 0.1000 |
Strike | 1.00 |
Expiry date | 2025-01-17 |
Day's range | 0.1000 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 137 |
CAMBRIDGE, Mass., June 04, 2024--Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Significant Revenue Growth Amidst Strategic Shifts and Clinical Developments
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript May 9, 2024 Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.75071 EPS, expectations were $0.24. AMLX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name […]